Atlas Venture Fund XI, L.P., 10% Owner at Xilio Therapeutics, Inc. (XLO), sold 1,000 shares at $0.64 ($640) on 2024-02-08, disclosed to the SEC on 2024-02-09.
Open-market sale of $640 XLO by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.64 | 267 | $171 | 26.7% |
| 2 | $0.64 | 733 | $469 | 73.3% |
| Total | $0.64 avg | 1,000 | $640 | 100% |